In addition, FGF-19 is highly expressed in mesenchymal stem cell-derived exosomes (Fig. 3b), which can induce the EMT through activation of the NPC cell FGF-19/FGFR-4 signaling pathway and promote tumor cell progression [122]. The gene discussed is FGF19; the disease is neoplasm.